NetworkNewsBreaks

WednesdayJan 19, 2022 11:12 am

NetworkNewsBreaks – Kronos Advanced Technologies Inc. (KNOS) Files Registration Statement to Fund Expansion up to $10M

Kronos Advanced Technologies (OTC: KNOS), a revenue-generating product development and production company that has significantly changed the way air is moved, filtered and disinfected, announced that it has filed a registration statement on Form S-1 with the Securities and Exchange Commission (the “SEC”) for a proposed offering of its shares. According to the update, KNOS entered into a common stock purchase agreement with Dutchess Capital Growth Fund LP to raise up to $10,000,000 via an equity financing facility. Kronos will use the funds raised to complete renovation of its electronic manufacturing facility, purchase advanced robotic automated manufacturing assembly lines, and…

Continue Reading

WednesdayJan 19, 2022 9:36 am

NetworkNewsBreaks – The Nifty Company to Launch ‘Blockchain Heroes: Retro Rebellion’

Some of the biggest brands in the WAX blockchain ecosystem are banding together in the continuing fight against the evil Centralizers for the Nifty Company’s latest Blockchain Heroes NFT collection release: Retro Rebellion, launching Jan. 21, 2022. From play-2-earn gaming giant, Splinterlands, to WAX fan favorites like Colonize Mars, HODL God and Graffiti Kings, the groundbreaking set will offer new and exclusive NFTs from 40 partners. “The WAX blockchain has been the birthplace of Blockchain Heroes ever since the summer of 2020. As the first major property to be released on the now-standard Atomic Assets, our previous three releases have…

Continue Reading

WednesdayJan 19, 2022 9:33 am

NetworkNewsBreaks – Microdose Psychedelic Insights’ Upcoming Conference to Showcase Top Companies, Newest Opportunities Within Psychedelics Sector

Microdose Psychedelic Insights, the leading guide to the business of psychedelics, will be hosting the upcoming Psychedelic Capital: January 2022 Conference in an entirely virtual format on Jan. 27, 2022, starting at 1:30 p.m. EST. The event will shine the spotlight on some of the top companies, latest IPOs, newest opportunities and deepest industry insights within the psychedelics sector. As part of a bimonthly investor conference series that dives deep into psychedelic medicine investment, the event will introduce attendees to a curated group of CEOs, capital advisors and investment luminaries from around the world. The event will start with a…

Continue Reading

TuesdayJan 18, 2022 4:09 pm

NetworkNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Provides Comments Regarding Study Examining Cannabinoids and SARS-CoV-2

Lexaria Bioscience (NASDAQ: LEXX), a global innovator in drug-delivery platforms, has commented on a recent study that indicated that cannabinoids have the potential to prevent as well as treat infection by SARS-CoV-2. The comments came from lead research scientist Dr. Richard van Breeman, who granted an interview with vice.com discussing the independent study. In his comments, Breemen observed that smoking or vaping of cannabis was likely not effective, but oral delivery was, causing Breeman to recommend oral administration of cannabis compounds. Lexaria is keenly interested in the study because the company is actively engaged in research with its exclusive DehydraTECH(TM)-powered cannabinoid formulations,…

Continue Reading

TuesdayJan 18, 2022 3:57 pm

NetworkNewsBreaks – IBN Eyes Continued Success on Heels of Astonishing Year

IBN (“InvestorBrandNetwork”), a multifaceted communications organization engaged in connecting public companies to the investment community, has announced that it recently reached a corporate milestone of 100+ client partners under active coverage. Since its first brand entered the global communications sector in January 2006, IBN has established an impressive track record, serving 500+ clients through an interconnected network of 50+ trusted brands designed to cater to diverse segments of the marketplace. Moreover, IBN has bolstered every aspect of its corporate communication efforts through valuable relationships with 5,000+ Core Syndication Partners and 150+ Events, allowing for wide dissemination of news and information.…

Continue Reading

TuesdayJan 18, 2022 3:33 pm

NetworkNewsBreaks – Growth Capital Acquisition Corp.’s (NASDAQ: GCAC) Pending Business Combination Partner to Present at Baird 2022 Conference

Growth Capital Acquisition Corp. (NASDAQ: GCAC) and its wholly owned subsidiary, GCAC Merger Sub Inc., previously entered into a business combination agreement with Cepton Technologies Inc., a Silicon Valley innovator and leader in high performance MMT(R) lidar solutions. Cepton today announced that its CEO Dr. Jun Pei and CFO Dr. Winston Fu will present virtually in the Baird 2022 Vehicle Technology and Mobility Conference at 1:10 p.m. ET on Tuesday, Jan. 25, 2022. According to the update, a link to the live webcast of management’s presentation along with additional investor materials and company information can be found on the investor…

Continue Reading

TuesdayJan 18, 2022 3:28 pm

NetworkNewsBreaks – FingerMotion Inc. (NASDAQ: FNGR) Releases Q3 2022 Financial Results

FingerMotion (NASDAQ: FNGR), a mobile data and services company, is reporting financial results for the third quarter, the period ended Nov. 30, 2021. Highlights of the report include quarterly revenue of $5.9 million, an increase of $1.02 million or 21% over Q3 2020; year-over-year quarterly growth in its telecommunications products & services business revenue of $2.8 million, a 580% increase over Q3 2020; quarterly loss in SMS & MMS business revenue of $1.78 million, or 40% compared to the same period in 2020; and no revenues in its big data division. In addition, the company showed gross profits of $967,075,…

Continue Reading

TuesdayJan 18, 2022 2:46 pm

NetworkNewsBreaks – SRAX Inc. (NASDAQ: SRAX) Announces Q4 Shares Repurchased, 1st Dividend Payment

SRAX (NASDAQ: SRAX), a financial technology company that unlocks data and insights for publicly traded companies through Sequire, its software-as-a-service (“SaaS”) platform, today announced the quantity of shares repurchased in the fourth quarter of 2021, as well as the first payment being made for the previously issued dividend. According to the update, the company repurchased approximately $800K worth of stock made up of 155,000 shares of common stock at an average price of $5.12 per share throughout the three months preceding Dec. 31, 2021. This was part of SRAX’s $10 million share buyback program announced on Aug. 17, 2021. “We…

Continue Reading

TuesdayJan 18, 2022 2:41 pm

NetworkNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) Releases Results of Harris Survey on Psychedelics as an Alternative Treatment

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has announced that nearly two-thirds (65%) of Americans who suffer from anxiety, depression and PTSD believe that psychedelic medicine, including ketamine, psilocybin and MDMA, should be available to patients with treatment-resistant anxiety, depression or PTSD. The online survey included 953 adults living in the United States who suffer from anxiety, depression or PTSD. Of those surveyed, 63% of those who have used prescription medications for treatment response that, while the medication helped, they still experienced residual feelings of anxiety, depression or…

Continue Reading

TuesdayJan 18, 2022 2:12 pm

NetworkNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), The Newly Partner to Set the Gold Standard for Psychedelic-Assisted Therapies

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, today announced its entry into a letter of intent (“LOI”) with The Newly Institute Inc. (“The Newly”), a Calgary, Alberta based company opening private inter-disciplinary mental health clinics across Canada. The companies will collaborate on expanding psychedelic-assisted psychotherapy to patients and, together, create the package of resources needed for patients and practitioners to successfully gain acceptance into Health Canada's Special Access Program (“SAP”). The Newly is the first partner under Mydecine's recently announced Special Access Support…

Continue Reading